Share Prices & Company Research

Market News

14 Nov 2025 | 13:53

Director dealings: 3i execs buy the dip, AstraZeneca CFO offloads shares

(Sharecast News) - London-listed companies 3i Group and AstraZeneca disclosed fresh director dealings on Wednesday, with senior executives at the private equity group adding to their holdings while AstraZeneca's finance chief sold American Depositary Shares. 3i Group said chief executive Simon Borrows purchased 30,000 shares at 3,366.7p each on the London Stock Exchange on 13 November.

Peter Wirtz, another senior manager, bought 25,000 shares at 3,415.53p on the same day.

A further transaction was reported on 14 November, when Karen McKellar, the wife of director Peter McKellar, acquired 4,000 shares at 3,344.6736p.

All three purchases were notified to the company this week.

The transactions followed a sharp fall in 3i's share price on Wednesday, when the stock slid 11.4% to 3,606p after the FTSE 100 group flagged a tougher investment environment despite reporting a stronger second quarter.

Borrows said at the time that the private equity portfolio had "maintained good momentum" but warned that the transaction market and wider backdrop would remain challenging into the second half of the financial year.

The update highlighted continued strong growth at discount retailer Action, which drove a 13% total return and lifted net asset value to 2,857p per share.

AstraZeneca meanwhile reported that chief financial officer Aradhana Sarin sold 15,000 American Depositary Shares on 12 November at a price equivalent to $88.6345 per ordinary share.

The sale was executed on the Nasdaq, and disclosed to the company a day later.

Two ADSs represent one AstraZeneca share.

It came as AstraZeneca's shares traded near record highs, buoyed by stronger-than-expected quarterly earnings and a US drug-pricing agreement reached in October.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Resolute Mining Limited Npv (di) (RSG) Director name: Parker ,Adrienne Amount purchased: 5,263 @ $4,894.59 Value: $21,242,043.66

London Btc Company Limited Npv (di) (BTC) Director name: Lenigas,David Amount purchased: 1,000,000 @ 350.00p Value: £3,500,000.00

3i Group (III) Director name: Borrows,Simon Amount purchased: 30,000 @ 3,366.70p Value: £1,010,009.99

Wpp (WPP) Director name: Rose ,Cindy Amount purchased: 50,000 @ 288.70p Value: £144,350.00

Wpp (WPP) Director name: Jansen ,Philip Amount purchased: 50,000 @ 285.10p Value: £142,550.00

Asiamet Resources Limited (di) (ARS) Director name: Djauhari,Eva Armila Amount purchased: 7,911,115 @ 1.50p Value: £118,666.72

Smiths News (SNWS) Director name: Malhotra,Manju Amount purchased: 30,006 @ 66.30p Value: £19,893.98

Experian (EXPN) Director name: DeRose,Kathleen Amount purchased: 250 @ $44.53 Value: $9,179.93

Xp Factory (XPF) Director name: Bird,Graham Amount purchased: 1,327 @ 11.30p Value: £149.95

Xp Factory (XPF) Director name: Harpham,Richard Amount purchased: 1,327 @ 11.30p Value: £149.95

Top Director Sells

Astrazeneca (AZN) Director name: Sarin,Aradhana Amount sold: 15,000 @ $88.63 Value: $1,096,328.42
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new portfolio or transferring your portfolio from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.